Home / Health / Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak

Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak

Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma

Premium

Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects, Haryana Health Minister Vij said

Press Trust of India

1 min read Last Updated : Jul 17 2020 | 4:29 PM IST

The human trial of Bharat Biotech's anti-Covid-19 vaccine Covaxin began at Rohtak's Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted.

Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today, Vij, who is also the Home and Science & Technology minister said.

Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects, Vij further said in his tweet.

ALSO READ: Coronavirus LIVE updates: India cases rise to 1,005,760; Delhi 118,645

Bharat Biotech got the country's drug regulator's approval to start clinical

Topics : Bharat Biotech COVID-19 Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in